vs
Side-by-side financial comparison of Butterfly Network, Inc. (BFLY) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
Butterfly Network, Inc. is the larger business by last-quarter revenue ($26.5M vs $16.9M, roughly 1.6× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 25.0%). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 11.1%).
Butterfly Network, Inc. is a digital health company that develops, manufactures and sells affordable, portable whole-body ultrasound devices powered by proprietary semiconductor technology. It serves clinical professionals, healthcare facilities, and home care users across global markets, with a core mission to expand access to medical imaging for underserved communities.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
BFLY vs FVCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $26.5M | $16.9M |
| Net Profit | $-12.7M | — |
| Gross Margin | 68.9% | — |
| Operating Margin | -21.2% | 43.7% |
| Net Margin | -47.8% | — |
| Revenue YoY | 25.0% | 4377.5% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.05 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $26.5M | — | ||
| Q4 25 | $31.5M | $16.9M | ||
| Q3 25 | $21.5M | $416.0K | ||
| Q2 25 | $23.4M | $15.8M | ||
| Q1 25 | $21.2M | $382.0K | ||
| Q4 24 | $22.4M | $378.0K | ||
| Q3 24 | $20.6M | $412.0K | ||
| Q2 24 | $21.5M | $415.0K |
| Q1 26 | $-12.7M | — | ||
| Q4 25 | $-15.3M | — | ||
| Q3 25 | $-34.0M | $5.6M | ||
| Q2 25 | $-13.8M | $5.7M | ||
| Q1 25 | $-14.0M | $5.2M | ||
| Q4 24 | $-18.1M | — | ||
| Q3 24 | $-16.9M | $4.7M | ||
| Q2 24 | $-15.7M | $4.2M |
| Q1 26 | 68.9% | — | ||
| Q4 25 | 67.3% | — | ||
| Q3 25 | -17.5% | — | ||
| Q2 25 | 63.7% | — | ||
| Q1 25 | 63.0% | — | ||
| Q4 24 | 61.5% | — | ||
| Q3 24 | 59.5% | — | ||
| Q2 24 | 58.6% | — |
| Q1 26 | -21.2% | — | ||
| Q4 25 | -53.0% | 43.7% | ||
| Q3 25 | -163.5% | — | ||
| Q2 25 | -68.9% | 45.9% | ||
| Q1 25 | -87.0% | — | ||
| Q4 24 | -77.5% | — | ||
| Q3 24 | -83.9% | — | ||
| Q2 24 | -80.2% | — |
| Q1 26 | -47.8% | — | ||
| Q4 25 | -48.5% | — | ||
| Q3 25 | -158.1% | 1341.1% | ||
| Q2 25 | -59.2% | 36.0% | ||
| Q1 25 | -65.8% | 1352.1% | ||
| Q4 24 | -81.0% | — | ||
| Q3 24 | -82.3% | 1133.3% | ||
| Q2 24 | -73.1% | 1001.2% |
| Q1 26 | $-0.05 | — | ||
| Q4 25 | $-0.06 | $0.31 | ||
| Q3 25 | $-0.13 | $0.31 | ||
| Q2 25 | $-0.06 | $0.31 | ||
| Q1 25 | $-0.06 | $0.28 | ||
| Q4 24 | $-0.09 | $0.27 | ||
| Q3 24 | $-0.08 | $0.25 | ||
| Q2 24 | $-0.07 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $138.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $191.2M | $253.6M |
| Total Assets | $285.9M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $138.0M | — | ||
| Q4 25 | $150.5M | — | ||
| Q3 25 | $144.2M | — | ||
| Q2 25 | $148.1M | — | ||
| Q1 25 | $155.2M | — | ||
| Q4 24 | $88.8M | — | ||
| Q3 24 | $93.8M | — | ||
| Q2 24 | $102.1M | — |
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $253.6M | ||
| Q3 25 | $203.8M | $249.8M | ||
| Q2 25 | $232.8M | $243.2M | ||
| Q1 25 | $239.7M | $242.3M | ||
| Q4 24 | $168.8M | $235.4M | ||
| Q3 24 | $181.8M | $230.8M | ||
| Q2 24 | $194.3M | $226.5M |
| Q1 26 | $285.9M | — | ||
| Q4 25 | $296.5M | $2.3B | ||
| Q3 25 | $290.0M | $2.3B | ||
| Q2 25 | $313.3M | $2.2B | ||
| Q1 25 | $318.4M | $2.2B | ||
| Q4 24 | $256.1M | $2.2B | ||
| Q3 24 | $265.3M | $2.3B | ||
| Q2 24 | $273.1M | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-13.9M | $23.9M |
| Free Cash FlowOCF − Capex | — | $23.8M |
| FCF MarginFCF / Revenue | — | 140.7% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-13.9M | — | ||
| Q4 25 | $9.0M | $23.9M | ||
| Q3 25 | $-2.9M | $7.6M | ||
| Q2 25 | $-7.2M | $3.3M | ||
| Q1 25 | $-11.7M | $5.4M | ||
| Q4 24 | $-3.1M | $18.2M | ||
| Q3 24 | $-7.9M | $4.7M | ||
| Q2 24 | $-10.0M | $1.6M |
| Q1 26 | — | — | ||
| Q4 25 | $7.9M | $23.8M | ||
| Q3 25 | $-3.9M | $7.6M | ||
| Q2 25 | $-8.1M | $3.3M | ||
| Q1 25 | $-12.0M | $5.4M | ||
| Q4 24 | $-3.5M | $18.1M | ||
| Q3 24 | $-8.3M | $4.6M | ||
| Q2 24 | $-10.7M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | 25.2% | 140.7% | ||
| Q3 25 | -18.2% | 1818.0% | ||
| Q2 25 | -34.5% | 20.8% | ||
| Q1 25 | -56.7% | 1413.6% | ||
| Q4 24 | -15.8% | 4786.0% | ||
| Q3 24 | -40.5% | 1121.8% | ||
| Q2 24 | -50.0% | 361.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 0.3% | ||
| Q3 25 | 4.7% | 0.2% | ||
| Q2 25 | 3.8% | 0.1% | ||
| Q1 25 | 1.7% | 4.2% | ||
| Q4 24 | 1.8% | 37.3% | ||
| Q3 24 | 2.0% | 14.1% | ||
| Q2 24 | 3.4% | 12.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFLY
| Product | $14.7M | 55% |
| Software and other services | $11.9M | 45% |
FVCB
Segment breakdown not available.